Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment
Health care system decision makers face challenges in allocating resources for screening, diagnosis and treatment of hepatitis C. Approximately 240,000 individuals are infected with the hepatitis C virus (HCV) in Canada. Populations most affected by HCV include Indigenous people, people who inject drugs, immigrants and homeless or incarcerated populations as well as those born between 1946 and 1965. Curative but expensive drug regimens of novel direct acting antivirals (DAAs) are available. We aim to identify social values from academic literature for inclusion in health technology assessments.
Year of Publication: 2020
Authors: Caroline O’Keefe-Markman, Kristina Dawn Lea, Christopher McCabe, Elaine Hyshka, Tania Bubela
Journal Title: BMC Public Health